Hims Labs is best when you want an app-native preventive blood panel — booked, drawn through Quest, and read inside one telehealth app. AMORTAL is different: it isn't a lab or an app. It takes results you already have and keeps them in an independent, cross-provider memory, turning each one into a ranked next action, a watchlist, and an outcome loop.
Hims Labs built a consumer-friendly on-ramp to bloodwork: a broad preventive panel processed by Quest Diagnostics, booked and read inside one telehealth app, with results connected to app-based guidance and treatment pathways. It answers the question “what do my numbers look like, and what does this app suggest?” in a single, low-friction place.
It is deliberately built around one app and the treatments that app offers — which is great for an app-native preventive start, but means your data and the decisions around it live inside one product. That’s the gap this page is about. Below is a fair, source-backed look at what Hims Labs is excellent for, and where AMORTAL fits as an independent decision layer on top. It’s educational, not medical advice.
+
Use Hims Labs for the data. Use AMORTAL to decide what the data should change, what to ignore, what to watch, and when to retest.
The short version: who each is for
These two aren’t really competitors — one produces app-native data, the other decides what to do with it across your life. Here’s the honest split.
Which one fits which job
Hims LabsBest for app-native preventive labsA broad preventive blood panel processed by Quest, booked and read inside one telehealth app with app-based guidance attached. Strongest when you want a low-friction, app-native entry point to bloodwork that lives next to telehealth care.
AMORTALBest for deciding what to do nextNot a lab and not an app you live inside. An independent, longitudinal decision layer that reads whatever results you already have — from Hims or anywhere — and returns one ranked next action, a watchlist, a clinician-ready question, and an outcome loop. Including when to do nothing.
This isn't an "A beats B." Hims Labs answers what are my numbers, in one app; AMORTAL answers what should they change, across everything you use. The strongest setup uses both.
Hims Labs vs AMORTAL, at a glance
Tap between the two to see what each is actually responsible for.
What each one owns
Same goal — better decisions from your blood — split into the app-native data job and the independent decision job.
The data + entry layer
Hims Labs runs an app-native preventive panel — Hims advertises 130+ tests across 10 health areas, processed by Quest Diagnostics, with the draw bookable at Quest locations through the app and results read alongside telehealth guidance.
You want a low-friction, app-native way to get a broad preventive panel with guidance and telehealth in one place. Verify the current marker count, price, partner network and what's treatment-linked before you buy.
The independent decision layer
AMORTAL doesn't draw blood and isn't an app you live inside. It takes your Hims results (or any source's), normalises them into a cross-provider memory, and produces one ranked next action, a watchlist, a clinician-ready question, and an outcome loop — with restraint built in.
You already have results and the real question is "what now, across everything I use?" — what to change, what to ignore, what to watch, and when a retest is actually worth it.
AMORTAL has no direct Hims integration — you bring the data in by upload or manual entry.
The comparison, row by row
| Dimension | Hims Labs | AMORTAL |
|---|---|---|
| Best use case | App-native preventive baseline | Deciding what the data should change |
| Collection method | Blood draw at Quest locations (booked via app) | No draws — works from results you already have |
| Lab partner / processing | Processed by Quest Diagnostics (as advertised) | Lab-agnostic; vendor-neutral by design |
| Biomarker breadth | 130+ tests across 10 health areas (advertised; verify current) | Doesn’t test; reads whatever you bring |
| Upload existing labs | Within its own app | Yes — bring Hims or any other results in |
| Wearable integration | Not the core product | Connects labs to Oura / Whoop / Apple Watch context |
| Clinician review | Telehealth providers (as advertised) | Clinician-compatible questions; not a clinician |
| Action plan depth | App guidance and treatment pathways | One ranked next best action, plus restraint |
| Retesting cadence | Re-test through the app | Tells you when not to retest yet |
| Result trend tracking | Trends inside the Hims app | Longitudinal memory across providers and time |
| Abnormal-result handling | Flags + telehealth review (as advertised) | Safety-gated; routes urgent flags to a clinician, never diagnoses |
| Data portability | Your results live in the Hims app | Cross-provider memory you carry with you |
| Cost model | Via Hims (verify current) | Decision layer — founding membership |
| Where AMORTAL fits | App-native panel in | → ranked decision, watchlist, and outcome loop out |
Provider rows describe what Hims publicly advertises as of June 2026 — pricing, marker count, lab processing and what's treatment-linked change often, so confirm the current details on Hims's own pages before buying. Sources are listed at the foot of this page.
Which one fits what you actually want
| What you want | Reach for |
|---|---|
| App-native labs and telehealth guidance in one place | Hims Labs |
| A low-friction preventive entry point to bloodwork | Hims Labs |
| My data to live beyond one app, across providers | AMORTAL |
| I already have results — tell me what to do next | AMORTAL |
| A clinician-ready question, not an in-app nudge | AMORTAL |
| To keep a finding separate from any product it could sell me | AMORTAL |
| To know whether a change actually worked | AMORTAL |
| To know whether I should retest yet | AMORTAL |
How AMORTAL complements Hims Labs
The model is simple: let Hims do the testing it does well, then run the result through a decision process instead of a single app’s dashboard.
- Bring the result in. Upload your Hims Labs report or enter the key markers — there's no direct integration, so you carry the data out of the app and into independent memory.
- Normalise into memory. AMORTAL files each biomarker into a longitudinal, cross-provider record, not a one-off in-app screen.
- Connect the context. Results are linked to your goals, symptoms, wearables, medications and constraints.
- Activate the standards. The guidelines and decision rules that actually apply to your situation switch on.
- Produce a Decision Contract. One change at a time, with the expected signal and the window written down in advance.
- Rank one Next Best Action. Not ten. The single highest-value move — which may be "do nothing yet."
- Set the watchlist. Markers worth re-checking get an expected direction and a recheck window.
- Close the loop. When your next panel or outcome signal arrives — from Hims or any source — AMORTAL checks whether the action worked, and keeps or discards it.
A decision loop, end to end
Here’s the same flow on a single example — illustrative numbers only, not a target or a reference range.
From a Hims result to a tracked outcome
Your Hims panel returns a borderline-high ApoB (illustrative only — not a target or reference range). In the app, that's a flagged number sitting next to suggested next steps.
AMORTAL files it next to any prior lipids, your goals, your current medications and your wearable trends — read as a trajectory across providers, not a single dot inside one app.
One lever, not five. The expected signal (ApoB direction) and the window to see it are written down before anything changes.
Framed as a clinician-ready question — "given this trend, is [one specific lever] the right first move?" — not a product nudge or a treatment directive AMORTAL has no authority to give.
The marker goes on watch with an expected direction and a recheck window — so you retest when it's informative, not because an app prompts you.
At the next draw — through Hims or anywhere — AMORTAL checks: did it move as expected? If yes, the change earns its place. If not, it's dropped — no story told over noise.
AMORTAL doesn't diagnose and isn't a substitute for your clinician — anything urgent goes to a professional, now.
Should this result live in one app, or in independent memory?
More data in one app isn’t the same as data you can act on across your life. Walk a result through this before you let it live in a single dashboard.
One app, or memory you carry?
Is this result tied to a specific treatment the platform sells?
Do you use more than one provider or source for health data?
Will you want this history in a year, across whatever you use then?
Worth an independent second read — keep it in cross-provider memory so the decision isn't anchored to one product.
AMORTAL's job — unify it into one memory so trends aren't trapped per-app.
Port it now — independent memory you carry beats a single app's dashboard.
Even so, capture the one decision and its expected signal before you move on.
Where Hims Labs is strongest — and where it isn’t
In fairness to both tools:
- Hims Labs is strongest when you want a low-friction, app-native way to get a broad preventive panel and have guidance and telehealth in the same place.
- Hims Labs may be less ideal if your real bottleneck isn’t getting data but deciding on data you already have across several sources — or if you’d rather a finding stay independent of any product an app could sell.
- Verify before you buy. Marker count, price, what’s processed by Quest and which results are treatment-linked all change — confirm the current details on Hims’s own pages.
- A panel is a beginning, not an answer. Some results will need a clinician; AMORTAL should never be read as a diagnosis.
Bring your results into a decision, not a dashboard
AMORTAL doesn’t need to be where you buy every blood test. The stronger model is to let an app-native provider like Hims Labs do the testing it does well, then use AMORTAL as the independent, longitudinal decision system around those results — one that isn’t tied to a single app or the treatments it sells. Upload a Hims report, or enter the markers that matter. AMORTAL turns the result into cross-provider memory, evaluates what’s still missing, ranks the next best action, sets a watchlist for the signals to expect, and later checks whether the action actually worked.
Already have results from Hims Labs? Bring them into AMORTAL and ask the only question that matters: “What should I do next?”
Sources
Provider claims describe what each company publicly advertised when this page was last fact-checked (26 June 2026). Pricing, marker counts, lab processing and what’s treatment-linked are volatile — verify on the official pages before purchase.
Hims Labs — what's tested, Quest processing, pricing and how appointments are booked.
Hims Labs FAQ — panel detail, the 130+ tests across 10 areas, and Quest locations.
Educational only — this is not medical advice or a diagnosis. Talk to a licensed clinician about your own numbers, targets, and any treatment decisions.
Frequently asked
Can I use AMORTAL with my Hims Labs results?
Yes — that's the intended use. Hims Labs gives you an app-native preventive panel processed by Quest; you bring those results into AMORTAL by uploading the report or entering the key markers. AMORTAL normalises them into a longitudinal, cross-provider memory, connects them to your goals, wearables and any protocols, and returns one ranked next action rather than an in-app dashboard. AMORTAL has no direct Hims integration; you bring the data in.
Does AMORTAL replace Hims Labs?
No. They do different jobs. Hims Labs is a data source and entry point — it books the draw, runs the panel through Quest, and surfaces results inside its app. AMORTAL is an independent decision layer that sits on top of whatever lab data you have. Many people keep Hims for the convenient app-native panel and use AMORTAL to decide what each result should change, what to ignore, and when to retest — without being anchored to one product.
Does AMORTAL order the test for me?
No. AMORTAL is not a lab or a draw network and does not order or sell tests. It works from results you already have — from Hims Labs, a clinician, or any other source. If a decision genuinely needs a test you don't have yet, AMORTAL will say so and tell you which one would actually change the decision, rather than encouraging you to test everything.
What does AMORTAL do after my Hims results come in?
It files them into your health memory, activates the standards that apply to you, and produces a Decision Contract: one next best action, the single signal you'd expect it to move, and the window to watch. It also creates watchlist items for markers worth re-checking later — and, importantly, will tell you when the right move is to change nothing yet, instead of steering you toward a treatment pathway.
Is a bigger panel always better?
Not automatically. A broad preventive panel like Hims Labs' is genuinely useful as an entry point, but more markers also mean more borderline results that tempt over-reaction — especially inside an app that can link a finding to a product. AMORTAL evaluates whether a marker actually changes a realistic decision, whether the result is timely, whether a clinician should weigh in, and what downstream signal to watch — so breadth becomes useful instead of noisy.
My Hims results live in the Hims app — why move them into AMORTAL?
App-native data is genuinely convenient — everything sits in one place. But that data is also siloed in a single app and sits next to the treatments that app sells. AMORTAL keeps an independent, cross-provider memory and a clinician-ready decision trail that travels with you, and it respects prescription-class boundaries — framing actions as questions for your clinician rather than steering you toward any one pathway. You keep the convenience of Hims and add a layer that isn't tied to it.